Cardiff Oncology (CRDF) PT Raised to $25 at Maxim Group
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $0.96 -2.04%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Maxim Group analyst Naureen Quibria raised the price target on Cardiff Oncology (NASDAQ: CRDF) to $25.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
